Celgene Corp. Drug Buyers Denied Cert. In Antitrust Suit
A New Jersey federal judge Tuesday declined to certify a proposed consumer class in antitrust litigation accusing Celgene Corp. of creating a monopoly on two of its drugs, finding that the...To view the full article, register now.
Already a subscriber? Click here to view full article